TCDA News and Press, Tricida Inc. From 08/17/20

CureVac (NASDAQ: CVAC ) +47%  on making reasonable profit on COVID-19 vaccine. More news on: CureVac N.V., LMP Automotive Holdings, Inc., Microbot Medical Inc., Stocks on the move, , Read more ...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Volatility watch: Some of the volatility names to watch include Colony Capital (NYSE: CLNY ) , American Eagle Outfitters (NYSE: AEO ) and Brookfield Property Partners (NASDAQ: BPY ) with short interest positions on the rise. Virgin Galactic (NYSE: SPCE ) and National Beverage (NAS...

Tricida, Inc. (TCDA) Q2 2020 Earnings Conference Call August 05, 2020, 04:30 PM ET Company Participants Jackie Cossmon - SVP-IR and Communications Gerrit Klaerner - Founder, CEO and President Geoff Parker - CFO Conference Call Participants Phil Nadeau - Cowen & Company ...

Image source: The Motley Fool. Tricida Inc   (NASDAQ: TCDA) Q2 2020 Earnings Call Aug 5, 2020 , 4:30 p.m. ET Operator Continue reading

Tricida (NASDAQ: TCDA ) : Q2 GAAP EPS of $1.16 beats by $2.62 . More news on: Tricida, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Webcast Today at 4:30 pm Eastern Time Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chr...

Tricida, Inc. (Nasdaq: TCDA) today announced that it will report its second quarter 2020 financial results after the close of market on Wednesday, August 5, 2020. Tricida will host a conference call and webcast at 4:30 pm Eastern Time to discuss its financial results and business progress. Th...

Heron Therapeutics Advances Phase 2 Study of CINVANTI Heron Therapeutics Inc. ( HRTX ) announced that it has started its Phase 2 clinical study of CINVANTI. The company has started the trial after receiving a go-ahead from the FDA for its Investigational New Drug application for the drug...

Shares of Tricida, Inc. (NASDAQ: TCDA) are tumbling 38.5% at 1:45 p.m. EDT on Thursday after the pharmaceutical company disclosed the Food and Drug Administration (FDA) has found deficiencies in its application for approval of veverimer. Designed to bind to and remove excess acid in chronic...